For the very same reasons, we previously failed to detect a difference in the plasma concentration of IL-26 between patients with moderate and severe COVID-19—or a significant correlation with length of hospital stay—in a small cohort (n = 49) that we used in a recent pilot study (18). Here, IL26 is linked to COVID-19.